DABIGATRAN ETEXILÁT + PHARMA 110 MG CPS DUR 30
What is the maximum co-payment for DABIGATRAN ETEXILÁT +PHARMA?
If the insurance company contributes, the maximum co-payment is 786,36 Kč. The maximum pharmacy price is 953,58 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price. If the physician marks increased reimbursement on the prescription, the maximum co-payment is 786,58 Kč.
Does the medicine have reimbursement from public health insurance?
Yes, but the reimbursement conditions (reporting limit) have not been set.
Does DABIGATRAN ETEXILÁT +PHARMA have a counted co-payment set?
No, this medicine has no counted co-payment.
How much does the insurance company pay for one dispensed reimbursed pack?
167,22 Kč.
Does the insurance company pay a higher amount in some cases?
Yes, increased reimbursement exists. A physician with the required specialization may, under strictly defined conditions, set a second reimbursement of 167,00 Kč.
Does the medicine have an indication restriction?
Is it available without a medical prescription?
No, the medicine cannot be obtained without a prescription.
Which medical specialist may prescribe DABIGATRAN ETEXILÁT +PHARMA?
Prescription is not conditional on a medical specialization.
What is the composition of DABIGATRAN ETEXILÁT +PHARMA?
Dabigatran-etexilát-mesilát (126,83 mg), dabigatran-etexilát (110 mg), neznámá látka s kódem 3755, sodná sůl kroskarmelosy, neznámá látka s kódem 4987, ointmentek, neznámá látka s kódem 1833, neznámá látka s kódem 4336, mannitol, magnesium-stearát, oxid titaničitý, hypromelosa, červený oxid železitý, šelak, propylenglykol, neznámá látka s kódem 9970, černý oxid železitý, hydroxid draselný. More information about the composition can be found in the SPC, section 6.1.
Where can I find information about correct use of the medicine?
Which medicines are similar to DABIGATRAN ETEXILÁT +PHARMA?
The medicine belongs to ATC group B01AE07 – DABIGATRAN-ETEXILÁT. Medicines with the same active substance can be found here.
Who manufactures DABIGATRAN ETEXILÁT +PHARMA?
+pharma arzneimittel gmbh, Graz (A)
Is the medicine in shortage?
The latest report from the manufacturer is from 21. 8. 2025. Production was terminated with effect from 30. 11. 2025. The manufacturer lists medicines with the following code as a potential substitute:
What is the unique code for DABIGATRAN ETEXILÁT +PHARMA?
The medicine has code 0253234. Code details can be found here.
How many packs of DABIGATRAN ETEXILÁT +PHARMA were previously dispensed on prescriptions in Czechia?
Show prescription medicine consumption
How many packs of DABIGATRAN ETEXILÁT +PHARMA were previously dispensed on request forms in Czechia?
PODOBNÉ PŘÍPRAVKY:
The page was last updated on 07. 01. 2026